How To Trade (REPL) - news.stocktradersdaily.com
Yesterday • Google News
Replimune Group Inc (REPL)
US$ 7.41-5.73%
Price Chart
Key Statistics
Market Cap
$ 570.68M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
636.73K
52W High
$ 17.00
52W Low
$ 4.92
Dividend Yield
0.00%
Beta
0.68
Technicals
50-Day MA
9.4595
200-Day MA
11.2225
52 Week High
17
52 Week Low
4.92
About REPL
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.
Employees
331
Headquarters
Woburn, MA
CEO
Mr. Philip Astley-Sparke F.S.A.
Latest News
Universal obtains approval to start construction on 'Rip Ride Rockit' replacement - WESH
Yesterday • Google News
More alternatives to knee replacement surgery are emerging - The Washington Post
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg